世界の不安障害およびうつ病治療の市場規模は、2023年に124億3000万ドルと推定され、2024年から2030年にかけて3.6%のCAGRで成長すると予測されます。若年成人における不安やうつ病の増加は、ソーシャルメディアの過剰使用、学業のプレッシャー、経済的ストレスなど、さまざまな原因を伴う複雑な問題であり、これが市場の成長を後押ししています。若年成人は、通常18歳から30歳と定義され、不安や抑うつのリスクに最も脆弱な年齢層の1つです。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Anxiety Disorders and Depression Treatment Market Variables Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Anxiety Disorders and Depression Treatment Market Variables : Drugs Estimates & Trend Anaysis
4.1. Segment Dashboard
4.2. Anxiety Disorders and Depression Treatment Market Variables Market: Solution Movement Analysis, USD Million, 2023 & 2030
4.3. Antidepressants
4.3.1. Antidepressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Anxiolytics
4.4.1. Anxiolytics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Anticonvulsants
4.5.1. Anticonvulsants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Noradrenergic Agents
4.6.1. Noradrenergic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Atypical Antipsychotics
4.7.1. Atypical Antipsychotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Anxiety Disorders and Depression Treatment Market : Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Anxiety Disorders and Depression Treatment Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Depression
5.3.1. Depression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Anxiety
5.4.1. Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Anxiety Disorders and Depression Treatment Market : Distribution Channel Estimates & Tren Analysis
6.1. Segment Dashboard
6.2. Anxiety Disorders and Depression Treatment Market: End-user Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacies
6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Anxiety Disorders and Depression Treatment Market : Regional Estimates & Trend Analysis
7.1. Anxiety Disorders and Depression Treatment Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Pfizers Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. H. Lundbeck A/S
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Glaxo SmithKline Pharmaceuticals Ltd.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Merck & Co., Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Eli Lilly & Company
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. AstraZeneca
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Bristol-Myers Squibb
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Johnson & Johnson
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. AbbVie Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Sanofi
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
